NCT04287569

Brief Summary

The study aims as principal objective to show the association between reflectance intensity of mucosa at different wave lengths and

  • the presence of acute or chronic inflammation in stomach or rectum and normal mucosa;
  • the presence of glandular atrophy in stomach or intestinal metaplasia. The secondary objectives are:
  • to identify reflectance profile which characterize an acute or a chronic inflammation, a glandular atrophy or an intestinal metaplasia, respectively;
  • to find a correlation between the reflectance to different frequencies and intensity of inflammation according to Sydney Classification in stomach (Dixon M F 1994) and in rectum (Erben U 2014).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 16, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

February 27, 2020

Completed
6 months until next milestone

Study Start

First participant enrolled

September 2, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 22, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 22, 2021

Completed
Last Updated

August 28, 2023

Status Verified

April 1, 2022

Enrollment Period

1.3 years

First QC Date

December 16, 2019

Last Update Submit

August 25, 2023

Conditions

Keywords

digestive inflammationmultispectral imagingmultispectral gastroscopymultispectral coloscopy

Outcome Measures

Primary Outcomes (1)

  • Reflectance endoscopy for gastric mucosa with lesions

    The reflectance endoscopy for gastric and rectal mucosa in different wavelength of presence of the lesions, in comparison with anatomopathological analysis on gastric and rectal mucosa, to diagnosis acute and chronic inflammation, glandular atrophy and intestinal metaplasia. This outcome will show reflectance for mucosa in presence of lesions which classified by anatomopathological analysis: comparison report.

    Up to 12 months

Secondary Outcomes (3)

  • Statistic association between profiles of reflectance and anatomopathological classifications

    Up to 12 months

  • Correlation between reflectance and intensity of inflammation

    Up to 12 months

  • Sub-study: morphological comparison between 2D/3D reconstruction and endoscopist's description

    Up to 12 months

Study Arms (1)

video recording of endoscopy

EXPERIMENTAL

Record of sequences of video-endoscopy and the reflectance of light through fibroscopy

Device: Record during endoscopy of video-endoscopy sequences and reflectance

Interventions

Record of video-endoscopy sequences and reflectance, during endoscopy with biopsy.

video recording of endoscopy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients needing a digestive endoscopy under general anesthesia, or a rectoscopy without anesthesia, with indicators of systematic biopsy regardless of reason;
  • Aged ≥ 18 years;
  • Covered by a public health insurance regime;
  • Signed consent.

You may not qualify if:

  • History of gastric or rectal surgery regardless of nature;
  • Gastrointestinal bleeding by hematemesis or rectal bleeding;
  • Hemostasis disorders preventing biopsy.
  • Difficulties in understanding french language;
  • Pregnant or breast feeding woman;
  • Woman of childbearing age without reliable contraception;
  • Adult under legal protection with tutor or curator.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service Hépato-Gastroentérologie, Hôpital Ambroise Paré

Boulogne-Billancourt, Île-de-France Region, 92100, France

Location

Study Officials

  • Dominique Lamarque, MD, PhD

    Service Hépato-Gastroentérologie, Hôpital Ambroise Paré, Boulogne Billancourt

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 16, 2019

First Posted

February 27, 2020

Study Start

September 2, 2020

Primary Completion

December 22, 2021

Study Completion

December 22, 2021

Last Updated

August 28, 2023

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations